Related Experiment Video
Updated: May 15, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Characteristic Findings in Aborted Robot-Assisted Radical Prostatectomies
Kathryn E Fink1, Austin Drysch1, Nicole Handa1
1Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Robot-assisted radical prostatectomy (RARP) is rarely aborted, occurring in less than 1% of cases. Pelvic lipomatosis and higher BMI are key factors associated with aborted RARP procedures.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- Robot-assisted radical prostatectomy (RARP) is a common procedure for prostate cancer.
- Intraoperative abortion of RARP cases, though rare, can impact patient care and surgical planning.
Purpose of the Study:
- To determine the incidence and causes of aborted RARP procedures.
- To identify factors associated with aborted RARP cases.
Main Methods:
- Retrospective analysis of RARP cases performed by high-volume surgeons from January 2018 to June 2024.
- Comparison of clinical, radiologic, and pathologic characteristics between aborted and completed RARP cases.
- Analysis of imaging features in propensity-matched patients.
Main Results:
- The incidence of aborted RARP was 0.7% (26 out of 3316 cases).
- Leading causes included pelvic lipomatosis (35%), adhesions (27%), and cardiorespiratory events (12%).
- Higher body mass index (BMI) was significantly associated with aborted procedures (30.7 vs 27.8, p=0.015).
Conclusions:
- Aborted RARP is infrequent (<1%) among experienced surgeons.
- Pelvic lipomatosis and elevated BMI are significant risk factors for RARP abortion.
- Preoperative identification of pelvic lipomatosis and patient BMI can aid in counseling and decision-making.
More Related Videos
12:34Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
Published on: January 3, 2020
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022